Date & Location
Wednesday, November 2, 2022, 7:50 AM – 5:40 PM, Online, New York, NY
Specialties
Overview
Novel Treatments in Pediatric Hematopoietic Stem Cell Transplantation and Cellular Therapies Hematopoietic stem cell transplant (HSCT) and cellular therapy is a hyper-specialized field within the already specialized pediatric oncology world. This necessitates providers to stay current on the rapidly evolving science behind the care of these complex patients.
This one-day symposium will have a focus on topics curated for advanced practice providers, including a mix of foundations of HSCT in addition to current clinical developments in the field.Â
The focused topics will include advances in GVHD therapies, unique disease processes that are being transplanted more often in the current era, diagnostic findings of HSCT complications, and new clinical trials that our patients are undergoing including JSP for SCID, TCR modified T-cell therapy for sarcoma patients and expanded cord blood transplant for multiply relapsed leukemia.
Who Should Attend
This symposium is intended for advanced practice providers who will be caring primarily or be involved in the care of pediatric hemopoietic stem cell transplant patients.
- Discuss the role of allogeneic hematopoietic stem transplantation in the treatment of both malignant and non-malignant diseases
- Identify the how and why hematopoietic stem cell transplant conditioning regimens are selected
- Describe the pathophysiology and clinical management of common hematopoietic stem cell transplant complications and toxicities
- Gain knowledge of the new advancements in care of pediatric hematopoietic stem cell transplant patients, including new types of transplants and other alternatives such as gene therapy
- Summarize the mechanism of acute and chronic GVHD including prophylactic strategies, treatment (including new research based therapies) and supportive care
 Topics:
Advances in Treatment of acute GVHD.mp4
Advances in Treatment of acute GVHD.pdf
APP-Peds-BMT-brochure.pdf
Bone Marrow Failure Syndromes Fanconi Anemia.mp4
Bone Marrow Failure Syndromes Fanconi Anemia.pdf
Complications from HSCT Q&A.mp4
Conditioning Regimens Graft Sources.mp4
Conditioning Regimens Graft Sources.pdf
Dermatology Presentation and Treatment Markova.mp4
Dermatology Presentation and Treatment Markova.pdf
Dermatology Presentation and Treatment Queliza.mp4
Dermatology Presentation and Treatment Queliza.pdf
Expanded Cord Blood for Relapsed Leukemia.mp4
Expanded Cord Blood for Relapsed Leukemia.pdf
Foundations of Pediatric Hematopoetic Stem Cell Transplant (HSCT) and Cell Therapie.mp4
Foundations of Pediatric Hematopoetic Stem Cell Transplant (HSCT) and Cell Therapie.pdf
Graft Vs. Host Disease in the Pediatric HSCT Patient Q&A.mp4
HSCT for Epidermolysis Bullosa and Other Metabolic Syndromes.mp4
HSCT for Epidermolysis Bullosa and Other Metabolic Syndromes.pdf
Jasper Antibody for SCID (Severe Compromised Immunodeficiency).mp4
Jasper Antibody for SCID (Severe Compromised Immunodeficiency).pdf
Newest Clinical Trials Q&A.mp4
Patient Perspective – My life after Transplant.mp4
Patient Perspective – My life after Transplant.pdf
Post-Transplant Lymphoproliferative Disease (PTLD) and the use of EBV CTLs.mp4
Post-Transplant Lymphoproliferative Disease (PTLD) and the use of EBV CTLs.pdf
Pulmonary GVHD Picture.mp4
Pulmonary GVHD Picture.pdf
Sickle Cell Disease.mp4
Sickle Cell Disease.pdf
Sinusoidal Obstructive Syndrome (SOS)- Radiographic Findings.mp4
Sinusoidal Obstructive Syndrome (SOS)- Radiographic Findings.pdf
Starting with Basics Q&A.mp4
TCR-modified T-cell Therapy.mp4
TCR-modified T-cell Therapy.pdf
Transplant Associated Thrombotic Microangiopathy (TMA).mp4
Transplant Associated Thrombotic Microangiopathy (TMA).pdf
Transplant for Nonmalignant Diseases Q&A.mp4
